Prognostic significance of EGF receptor expression in early glottic cancer

Auris Nasus Larynx

Volumn 31, Issue 4, 2004, Pages 417-424

  Demiral, A N ^a,c   Sarioglu, S ^a   Birlik, B ^a   Sen, M ^a,b   Kinay, M ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c 35350 Uckuyular T   (Turkey)

Author keywords

EGF receptor; Laryngeal cancer; Prognostic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ANTERIOR COMMISSURE; ARTICLE; CANCER GRADING; CANCER STAGING; CHI SQUARE DISTRIBUTION; COMPUTER PROGRAM; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 9644279500     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2004.05.003     Document Type: Article

References (30)

1. Jin J., Liao Z., Gao L., Huang X., Xu G. Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of Medical Sciences. Int. J. Radiat. Oncol. Biol. Phys. 54:2002;471-478
2. Marshak G., Brenner B., Shvero J., Shapira J., Ophir D., Hochman I., et al. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int. J. Radiat. Oncol. Biol. Phys. 43:1999;1009-1013
3. Mendenhall W.M., Amdur R.J., Morris C.G., Hinerman R.W. T1-2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J. Clin. Oncol. 19(20):2001;4029-4036
4. Hermans R., Feron M., Bellon E., Dupont P., Van den Bogaert W., Baert A.L. Laryngeal tumor volume measurements determined with CT: a study on intra- and inter-observer variability. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;553-557
5. Lusinchi A., Dube P., Wibault P., Kunkler I., Luboinski B., Eschwege F. Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiother. Oncol. 15(4):1989;313-319
6. Mendenhall W.M., Parsons J.T., Million R.R. Management of T1 and T2 squamous cell carcinoma of the glottic larynx. Mayo Clin. Proc. 67:1992;703-705
7. Sakata K., Aoki Y., Karasawa K., Hasezawa K., Muta N., Nakagawa K., et al. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;1059-1064
8. Rudoltz M.S., Benammar A., Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;767-772
9. Stevenson J.M., Juillard G.J., Selch M.T. Stages 1 and 2 epidermoid carcinoma of the glottic larynx: involvement of the anterior commissure. Radiology. 182:1992;797-799
10. Gupta A.K., McKenna W.G., Weber C.N., Feldman M.D., Goldsmith J.D., Mick R., et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin. Cancer Res. 8(3):2002;885-892
11. Almadori G., Cadoni G., Galli J., Ferrandina G., Scambia G., Exarchakos G., et al. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int. J. Cancer. 84(2):1999;188-191
12. Maurizi M., Almadori G., Ferrandina G., Distefano M., Romanini M.E., Cadoni G., et al. Prognostic significance of EGFR in laryngeal squamous cell carcinoma. Br. J. Cancer. 74(8):1996;1253-1257
13. Wen Q.H., Miwa T., Yoshizaki T., Nagayama I., Furukawa M., Nishijima H. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope. 106(7):1996;884-888
14. Weber R.S., Pathak S., Frankenthaler R., Gallick G.E., Sacks P.G. Effect of epidermal growth factor (EGF) on a newly established head and neck squamous carcinoma cell line. Otolaryngol. Head Neck Surg. 99:1988;567-573
15. Santini J., Formento J.L., Francoual M., Milano G., Schneider M., Dassonville O., et al. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck. 13:1991;132-139
16. Scambia G., Panici P.B., Battaglia F., Ferrandina G., Almadori G., Paludetti G., et al. Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer. 67:1991;1347-1351
17. Roy-Chaudhury P., Jones M.C., MacLeod A.M., Haites N.E., Simpson J.G., Power D.A. An immunohistochemical study of epidermal growth factor receptor and neu receptor expression in proliferative glomerulonephritis. Pathology. 25:1993;327-332
18. Harris AL. EGFR signal transduction. Signal 2001;1:2-4.
19. Grandis J.R., Melhem M.F., Barnes E.L., Tweardy D.J. Quantitative immunuhistochemical analysis of transforming growth factor alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 78(6):1996;1284-1292
20. Ang K.K., Berkey B.A., Tu X., Zhang H.Z., Katz R., Hammond E.H., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 62:2002;7350-7356
21. Ishitoya J., Toriyama M., Oguchi N., Kitamura K., Ohshima M., Asano K., et al. Gene amplification and overexpression of EGF receptors in squamous cell carcinomas of head and neck. Br. J. Cancer. 59:1989;559-562
22. Maurizi M., Scambia G., Benedetti Panici P., Ferrandina G., Almadori G., Paludetti G., et al. EGF receptor expression in primary laryngeal cancer: correlation with clinicopathologic features and prognostic significance. Int. J. Cancer. 52:1992;862-866
23. Sheridan M.T., O'Dwyer T., Seymour C.B., Mothersill C.E. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiat. Oncol. Invest. 5:1997;180-186
24. Akimoto T, Hunter NR, Buchmiller L, Mason K, Ang KK, Milas L. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res 1999;5(10):2884-2890.
25. Kamijo T., Yokose T., Hasebe T., Yonou H., Sasaki S., Hayashi R., et al. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy. Clin. Cancer Res. 6:2000;3159-3165
26. Miyaguchi M., Olofsson J., Hellquist H.B. Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin. Otolaryngol. 16:1991;466-469
27. Kavukçu S., Soylu A., Türkmen M., Kuralay F., Yilmaz O., Sarioglu S. Unilateral ureteroperitoneostomy in the management of hypoproteinemia in nephrotic rats with normal renal function. Tohoku J. Exp. Med. 201(2):2003;67-73
28. Grandis J.R., Melhem M.F., Gooding W.E., Day R., Holst V.A., Wagener M.M., et al. Levels of TGF alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst. 90(11):1998;824-832
29. Milas L., Mason K., Hunter N., Petersen S., Yamakawa M., Ang K., et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin. Cancer Res. 6:2000;701-708
30. Bonner J.A., Raisch K.P., Trummell H.Q., Robert F., Meredith R.F., Spencer S.A., et al. Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. J. Clin. Oncol. 18:2000;47S-53S